Premature ventricular contractions (PVCs)

Premature ventricular contractions, commonly known as PVCs, are a type of cardiac arrhythmia that occurs when the heart's ventricles contract earlier than expected in the normal cardiac cycle. These abnormal heartbeats originate from the ventricular tissue rather than from the sinoatrial node, which normally controls the heart's rhythm. PVCs are among the most commonly encountered cardiac arrhythmias in cats and can occur in both healthy cats and those with underlying heart disease. While occasional PVCs may be detected incidentally during routine veterinary examinations, frequent or complex PVCs may indicate more serious cardiac conditions requiring thorough evaluation and management.

The underlying cause of PVCs in cats can vary significantly, ranging from structural heart disease such as hypertrophic cardiomyopathy to metabolic disturbances, electrolyte imbalances, or systemic illnesses. In some cases, PVCs occur in cats with apparently normal hearts, though the presence of frequent PVCs always warrants investigation to rule out underlying cardiac or systemic disease. The abnormal electrical impulses that generate PVCs arise from irritable foci within the ventricular myocardium, disrupting the normal coordinated contraction pattern of the heart and potentially affecting cardiac output.

The clinical significance of PVCs depends largely on their frequency, complexity, and the presence of underlying heart disease. Isolated, infrequent PVCs in cats without structural heart disease may have minimal impact on overall health and quality of life. However, frequent PVCs, particularly those occurring in runs or pairs, can compromise cardiac function, reduce cardiac output, and potentially predispose affected cats to more serious ventricular arrhythmias. Cats with concurrent heart disease and significant PVC burden face increased risks of sudden cardiac death and congestive heart failure progression.

Treatment for PVCs in cats focuses on addressing any underlying causes, managing concurrent heart disease, and using antiarrhythmic medications when indicated. The prognosis for cats with PVCs varies considerably based on the underlying etiology and the cat's response to treatment. Early detection through routine cardiac screening, particularly in breeds predisposed to heart disease, allows for timely intervention and improved outcomes. Working closely with a veterinarian or veterinary cardiologist ensures appropriate monitoring and treatment adjustments to maintain optimal cardiac health and quality of life for affected cats.

The causes of premature ventricular contractions in cats are diverse and can involve primary cardiac disease, systemic illness, metabolic disturbances, or idiopathic factors. The most common underlying cause of clinically significant PVCs in cats is structural heart disease, particularly hypertrophic cardiomyopathy, which affects the ventricular myocardium and creates conditions favorable for arrhythmia development. Other forms of cardiomyopathy, including dilated cardiomyopathy, restrictive cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy, can also predispose cats to ventricular ectopy. Congenital heart defects may additionally contribute to PVC development in affected cats.

Genetic factors play a significant role in PVC development, primarily through their influence on cardiac structure and function. Cats with inherited cardiomyopathies carry genetic mutations that alter cardiac muscle structure, electrical conduction properties, or both, increasing susceptibility to arrhythmias including PVCs. While specific genetic testing for arrhythmia susceptibility is not routinely available in cats, the hereditary nature of many feline cardiomyopathies means that cats from affected bloodlines face elevated risks. Certain breeds, including Maine Coons, Ragdolls, and British Shorthairs, have documented genetic predispositions to cardiomyopathy and associated arrhythmias.

Environmental and metabolic factors can trigger or exacerbate PVCs in cats regardless of underlying cardiac health. Electrolyte imbalances, particularly abnormalities in potassium, magnesium, or calcium levels, directly affect cardiac electrical activity and can promote ventricular ectopy. Hyperthyroidism, a common endocrine disorder in older cats, increases cardiac workload and can induce arrhythmias including PVCs. Systemic illnesses causing hypoxia, anemia, or acid-base disturbances may also trigger ventricular ectopy. Certain medications, toxins, and anesthetic agents can additionally provoke PVCs in susceptible cats.

Risk factors for PVC development extend beyond primary causes to include age, concurrent diseases, and physiological stressors. Middle-aged to older cats face increased PVC risk due to age-related cardiac changes and the higher prevalence of heart disease and systemic illness in this population. Cats with chronic kidney disease, diabetes mellitus, or other metabolic conditions may experience electrolyte disturbances that promote arrhythmias. Stress, pain, and fever can trigger sympathetic nervous system activation and catecholamine release, potentially inducing PVCs even in cats without underlying cardiac disease.

The mechanism by which PVCs develop involves abnormal electrical impulse generation within ventricular tissue. Under normal circumstances, the sinoatrial node initiates each heartbeat, with electrical impulses traveling through the atria to the atrioventricular node and then through the ventricular conduction system. PVCs occur when irritable foci within the ventricular myocardium spontaneously depolarize before receiving normal impulses, causing premature ventricular contraction. This ectopic electrical activity can result from enhanced automaticity of ventricular cells, triggered activity from abnormal calcium handling, or reentrant circuits within diseased myocardium. The resulting premature contraction typically produces a compensatory pause before the next normal heartbeat, which owners or veterinarians may detect as an irregular pulse.

Early warning signs of premature ventricular contractions in cats can be subtle and easily overlooked, as cats are masters at masking signs of illness. Some cats with occasional PVCs display no outward symptoms, with the arrhythmia discovered only during routine veterinary examination or cardiac screening. Attentive owners may notice mild changes such as slightly reduced activity levels or decreased interest in play, though these subtle signs are often attributed to normal aging or dismissed as insignificant. Cats experiencing more frequent PVCs may show intermittent episodes of weakness or unsteadiness that resolve quickly, leaving owners uncertain whether they witnessed anything abnormal.

Common symptoms of clinically significant PVCs include exercise intolerance, reduced activity levels, and reluctance to engage in previously enjoyed activities. Affected cats may tire more easily during play sessions or avoid climbing and jumping as they normally would. Some cats exhibit intermittent episodes of weakness or lethargy that occur unpredictably and resolve without intervention. Owners may notice their cat resting more frequently or preferring lower perches and ground-level resting spots. Respiratory changes, including slightly increased breathing rate or effort, may occur in cats with compromised cardiac function due to frequent PVCs.

Behavioral changes associated with PVCs often reflect the cat's response to feeling unwell or experiencing cardiac symptoms. Affected cats may become more withdrawn, seeking quiet hiding spots rather than engaging with family members. Changes in appetite can occur, with some cats showing decreased interest in food during symptomatic periods. Litter box habits may change if the cat experiences weakness or fatigue traveling to and from the box. Some cats vocalize more, particularly older cats who may cry out during episodes of cardiac discomfort or confusion. Sleep patterns may become disrupted, with affected cats appearing restless or changing preferred sleeping positions frequently.

Physical signs detectable during examination include an irregular heart rhythm with occasional pauses or extra beats, which veterinarians appreciate as pulse deficits when comparing heart rate to peripheral pulse rate. The heart sounds during PVCs differ from normal beats, with varying intensity depending on ventricular filling. Some cats with frequent PVCs develop audible heart murmurs or gallop rhythms reflecting concurrent cardiac disease. Mucous membrane color and capillary refill time may be abnormal in cats with significantly compromised cardiac output. Weight loss can occur in cats with chronic cardiac disease and persistent arrhythmias affecting their overall condition.

Symptom progression in cats with PVCs typically correlates with the underlying cause and PVC frequency. Cats with infrequent, isolated PVCs may remain asymptomatic indefinitely, while those with frequent or complex ventricular ectopy often show progressive symptom development. As PVC burden increases, cardiac output decreases, leading to more pronounced exercise intolerance and weakness. Cats with underlying cardiomyopathy may progress to congestive heart failure, developing respiratory distress from pulmonary edema or abdominal distension from pleural effusion. The transition from compensated to decompensated cardiac disease can occur gradually or rapidly depending on individual factors.

Emergency symptoms requiring immediate veterinary attention include collapse or syncope, severe respiratory distress with open-mouth breathing, prolonged weakness or inability to stand, and pale or blue-tinged gums. Sudden death can occur in cats with severe ventricular arrhythmias that deteriorate into ventricular fibrillation or sustained ventricular tachycardia. Any episode of collapse, even if brief with apparent full recovery, warrants urgent cardiac evaluation. Cats displaying acute respiratory distress should receive immediate emergency care, as this may indicate congestive heart failure requiring urgent treatment. Owners should not delay seeking veterinary attention when cats exhibit these serious symptoms, as rapid intervention can be life-saving.

Initial examination for suspected PVCs begins with a thorough physical examination focusing on cardiovascular assessment. The veterinarian will carefully auscultate the heart, listening for irregular rhythms, murmurs, gallop sounds, or other abnormalities. Pulse quality assessment helps identify pulse deficits where audible heartbeats do not produce palpable peripheral pulses, a hallmark of PVCs and other arrhythmias. The veterinarian will also evaluate respiratory sounds, check for jugular vein distension, assess mucous membrane color and capillary refill time, and examine for signs of fluid accumulation. A complete history including any observed symptoms, activity level changes, and family cardiac history helps guide diagnostic planning.

The gold standard diagnostic test for PVCs is the electrocardiogram, which records the heart's electrical activity and allows identification and characterization of arrhythmias. Standard in-hospital ECGs provide valuable snapshots but may miss intermittent PVCs that occur infrequently. Continuous Holter monitoring over 24 to 48 hours captures the full range of cardiac rhythm disturbances and quantifies PVC burden, providing essential information for treatment decisions. ECG analysis reveals PVC morphology, frequency, timing relative to normal beats, and presence of concerning patterns such as couplets, triplets, or runs of ventricular tachycardia. Blood pressure measurement should accompany ECG evaluation to assess overall cardiovascular status.

Additional diagnostic testing helps identify underlying causes and assess cardiac structure and function. Echocardiography provides detailed visualization of cardiac chambers, walls, valves, and function, identifying structural heart disease such as cardiomyopathy that may underlie PVC development. Blood tests including complete blood count, serum chemistry panel, and thyroid hormone levels help identify metabolic disturbances, electrolyte abnormalities, and systemic diseases contributing to arrhythmia. Thoracic radiographs assess heart size and shape, evaluate for pulmonary edema or pleural effusion, and examine the lungs and other thoracic structures. Specialized cardiac biomarkers such as cardiac troponin I and NT-proBNP may provide additional information about myocardial injury and cardiac stress.

Differential diagnosis involves distinguishing PVCs from other causes of irregular heart rhythm and identifying the specific type of ventricular ectopy present. Other arrhythmias producing irregular rhythms include atrial fibrillation, supraventricular premature complexes, and various conduction disturbances. The ECG morphology of PVCs is characteristic, with wide, bizarre QRS complexes that differ from the normal narrow complexes of supraventricular origin. Confirming the ventricular origin of premature beats and determining their clinical significance requires careful ECG interpretation, ideally by a veterinary cardiologist for complex cases. The diagnostic process also involves identifying or excluding underlying causes, as treatment approaches differ based on whether PVCs occur in structurally normal hearts versus those with cardiomyopathy or other cardiac disease.

Emergency treatment for cats presenting with symptomatic PVCs or ventricular arrhythmias focuses on stabilization and rhythm control. Cats in respiratory distress require immediate oxygen supplementation while diagnostic evaluation proceeds. Intravenous access allows rapid medication administration and fluid therapy if indicated. For cats with hemodynamically unstable ventricular arrhythmias, intravenous lidocaine provides rapid antiarrhythmic effect and can convert unstable rhythms to more stable patterns. Underlying conditions such as hyperthyroidism, severe electrolyte disturbances, or hypoxia require concurrent treatment to address arrhythmia triggers. Continuous ECG monitoring during the stabilization period allows assessment of treatment response and early detection of rhythm deterioration.

Medical management of chronic PVCs in cats involves antiarrhythmic medications chosen based on arrhythmia characteristics, underlying disease, and individual patient factors. Beta-blockers such as atenolol are commonly prescribed for cats with PVCs, particularly those with underlying hypertrophic cardiomyopathy, as they reduce heart rate, decrease myocardial oxygen demand, and have antiarrhythmic properties. Sotalol combines beta-blocking effects with class III antiarrhythmic activity and may be effective for cats with significant ventricular ectopy. Mexiletine, a sodium channel blocker, can be used alone or in combination with other antiarrhythmics for refractory ventricular arrhythmias. Medication selection, dosing, and monitoring protocols should be guided by a veterinarian or veterinary cardiologist experienced in feline cardiac disease.

Surgical intervention is rarely indicated for PVCs specifically but may be necessary for underlying conditions contributing to arrhythmia development. Cats with hyperthyroidism may benefit from thyroidectomy or radioactive iodine therapy to achieve long-term control of thyroid hormone levels and reduce cardiac stress. Pericardiocentesis may be required for cats with pericardial effusion contributing to cardiac dysfunction and arrhythmia. While catheter ablation procedures are performed in humans with certain refractory arrhythmias, these interventions are not routinely available or practical for most feline patients. Surgical treatment of congenital heart defects, when feasible, may reduce arrhythmia burden in affected cats.

Supportive care for cats with PVCs includes management of concurrent conditions and optimization of overall health. Cats with congestive heart failure require diuretic therapy, typically furosemide, to manage fluid accumulation. ACE inhibitors such as benazepril or enalapril may be prescribed for cats with certain types of heart disease to support cardiac function. Nutritional support focuses on maintaining appropriate caloric intake and addressing any specific dietary needs related to heart disease or concurrent conditions. Pain management and stress reduction help minimize sympathetic nervous system activation that can exacerbate arrhythmias. Maintaining stable body temperature and adequate hydration supports overall cardiovascular function.

Alternative and complementary treatment approaches may supplement conventional medical management for some cats with PVCs. Omega-3 fatty acid supplementation has shown antiarrhythmic properties in some studies and may benefit cats with cardiac disease. Taurine supplementation is essential for cats with taurine-deficient dilated cardiomyopathy but is not specifically antiarrhythmic. Acupuncture has been explored for various cardiac conditions though evidence specifically for feline arrhythmias is limited. Environmental modifications to reduce stress, including pheromone therapy and provision of quiet resting spaces, may help minimize triggers for arrhythmia in anxious cats. Any complementary therapies should be discussed with the treating veterinarian to ensure compatibility with conventional treatment.

Treatment decisions for cats with PVCs consider multiple factors including arrhythmia severity, underlying disease, patient tolerance of medications, owner capability for treatment administration, and financial considerations. Not all cats with PVCs require antiarrhythmic therapy, as occasional isolated PVCs in cats without structural heart disease may simply warrant monitoring. The decision to initiate treatment typically depends on PVC frequency, presence of complex ventricular ectopy, associated symptoms, and underlying cardiac disease severity. Treatment costs include diagnostic testing, medications, and ongoing monitoring, which can be substantial over time for chronic cardiac disease management. Open discussion with the veterinary team about treatment goals, expected outcomes, and practical considerations helps owners make informed decisions appropriate for their individual situations.

Recovery timeline for cats with PVCs varies considerably based on the underlying cause and treatment approach implemented. Cats with PVCs secondary to treatable conditions such as hyperthyroidism or electrolyte imbalances may show significant improvement within days to weeks once the underlying problem is addressed. Those requiring antiarrhythmic medication typically demonstrate treatment response within one to two weeks, though optimal medication dosing may require adjustment over several weeks to months. Cats with structural heart disease face ongoing management rather than true recovery, with the goal being long-term rhythm control and cardiac function preservation. Regular follow-up ECGs help track treatment response and guide therapy adjustments.

Post-treatment care for cats with PVCs requires dedication to medication administration and monitoring protocols. Owners must administer prescribed medications consistently, typically once or twice daily depending on the drug used. Following any dose changes or medication adjustments, close observation for side effects or symptom changes is essential. Activity recommendations depend on cardiac status, with most cats allowed normal activity levels once stable, though intense play or stressful situations may warrant avoidance in some cases. Follow-up appointments for ECG monitoring, echocardiography when indicated, and general assessment are scheduled based on individual patient needs, typically every three to six months for stable patients.

Prognosis for cats with PVCs depends heavily on the underlying etiology and response to treatment. Cats with idiopathic PVCs or those secondary to correctable metabolic disturbances often have excellent long-term prognoses with appropriate management. Those with structural heart disease face more guarded prognoses, with outcomes influenced by the type and severity of cardiomyopathy, response to cardiac medications, and development of complications such as congestive heart failure or thromboembolism. The frequency and complexity of ventricular ectopy also influence prognosis, with frequent, complex PVCs carrying higher risks than occasional isolated beats. Regular monitoring allows early detection of disease progression and timely treatment adjustments.

Long-term outlook for cats living with PVCs ranges from excellent to guarded depending on individual circumstances. Many cats with well-controlled arrhythmias maintain good quality of life for years with appropriate management. Owners should understand that cardiac disease in cats is typically progressive, and treatment goals focus on slowing progression and maintaining quality of life rather than cure. The risk of sudden cardiac death exists for cats with significant ventricular arrhythmias, though this risk decreases with effective treatment. Regular veterinary care, compliance with treatment recommendations, and attentive home monitoring for symptom changes optimize outcomes for cats with PVCs and allow early intervention when disease progresses.

Primary prevention of premature ventricular contractions focuses on identifying and managing conditions that predispose cats to arrhythmia development. Regular veterinary examinations allow early detection of heart disease, hyperthyroidism, and other conditions associated with PVC development. For breeds known to be predisposed to cardiomyopathy, cardiac screening echocardiography can identify structural heart disease before arrhythmias develop, allowing proactive management. Breeding programs that screen for cardiomyopathy and avoid breeding affected individuals help reduce the prevalence of inherited heart disease in susceptible breeds. Prospective cat owners should inquire about cardiac health history in parents and bloodlines when acquiring purebred cats from breeds with known cardiomyopathy predisposition.

Environmental prevention strategies support overall cardiac health and minimize arrhythmia triggers. Maintaining cats at healthy body weights reduces cardiac workload and associated stress on the heart. Providing a low-stress environment with appropriate enrichment, hiding spaces, and predictable routines helps minimize sympathetic nervous system activation that can trigger arrhythmias. Indoor housing protects cats from trauma, toxin exposure, and infectious diseases that could affect cardiac health. Avoiding exposure to known cardiotoxic substances, including certain plants, medications, and household chemicals, prevents toxic cardiac injury. Temperature regulation and preventing overheating reduces cardiac stress, particularly in cats with existing heart disease.

Dietary prevention involves providing appropriate nutrition to support cardiac health throughout life. High-quality commercial cat foods formulated to meet feline nutritional requirements provide essential nutrients including taurine, which is critical for cardiac function. Cats fed exclusively home-prepared or unconventional diets require careful attention to taurine content to prevent deficiency-related cardiomyopathy. Avoiding excessive sodium intake may benefit cats with heart disease, though severe sodium restriction is not typically necessary for cats without congestive heart failure. Maintaining adequate hydration supports overall cardiovascular function and helps prevent electrolyte disturbances. Consultation with a veterinarian regarding diet selection is particularly important for cats with diagnosed cardiac disease.

Health maintenance practices contribute to cardiac health and arrhythmia prevention throughout a cat's life. Annual or biannual veterinary examinations allow monitoring of cardiac status through physical examination and additional testing when indicated. Keeping vaccinations current prevents infectious diseases that can affect the heart, such as those caused by certain viruses. Regular parasite prevention protects against heartworm disease, which affects cats and can cause cardiac and respiratory problems. Dental health maintenance prevents periodontal disease, which has been associated with cardiac inflammation in some species. Managing chronic conditions such as kidney disease, diabetes, and hypertension appropriately helps maintain overall health and reduce cardiac stress.

Early intervention when risk factors or early signs of cardiac disease are identified provides the best opportunity to prevent or minimize arrhythmia development. Cats showing subtle signs of cardiac disease, such as mild murmurs or gallop rhythms, benefit from echocardiographic evaluation to assess cardiac structure and function. Early treatment of hyperthyroidism prevents prolonged cardiac stress and associated arrhythmias. Monitoring bloodwork in senior cats helps identify electrolyte disturbances or metabolic conditions before they cause cardiac complications. Working proactively with a veterinarian to monitor cardiac health in predisposed breeds or individual cats with risk factors allows intervention at the earliest possible stage.

Daily management of cats with premature ventricular contractions requires consistency in medication administration and attention to routine. Antiarrhythmic medications should be given at the same times each day to maintain stable blood levels and consistent rhythm control. Owners should establish a medication routine that integrates with daily activities, making missed doses less likely. Keeping a medication log helps track administration and provides valuable information for veterinary appointments. Activity levels for most cats with well-controlled PVCs can remain relatively normal, though owners should avoid forcing intense play sessions and allow the cat to self-regulate activity. Monitoring for any changes in behavior, activity tolerance, or breathing pattern helps detect early signs of disease progression.

Home environment modifications support the comfort and safety of cats with cardiac arrhythmias. Providing easily accessible resting spots, including options at various heights with low-effort access, accommodates cats who may experience intermittent weakness or fatigue. Ensuring litter boxes are conveniently located minimizes physical exertion for bathroom needs. Keeping food and water dishes at comfortable heights and locations encourages adequate intake. Maintaining a calm, quiet environment reduces stress-related sympathetic activation that can exacerbate arrhythmias. Temperature control prevents overheating, which increases cardiac workload. Removing or securing potential hazards reduces injury risk for cats who might experience weakness or instability.

Quality of life maintenance remains the primary goal for cats living with PVCs and associated cardiac conditions. Most cats with well-managed arrhythmias can continue enjoying normal feline activities including play, social interaction, and environmental exploration within their capabilities. Mental stimulation through puzzle feeders, window perches, and interactive toys keeps cats engaged without requiring excessive physical exertion. Maintaining familiar routines and social bonds provides emotional comfort. Owners should observe their cat's preferences and adjust activities accordingly, recognizing that individual cats have varying energy levels and interests. Quality of life assessment focuses on the cat's ability to enjoy daily activities, maintain comfort, and engage with their environment and family.

Ongoing monitoring and veterinary care are essential components of long-term management for cats with PVCs. Owners should learn to check their cat's resting respiratory rate at home, as increases may indicate fluid accumulation from heart failure progression. Noting any changes in appetite, activity level, or behavior provides important information for veterinary assessment. Regular recheck appointments allow ECG monitoring to assess arrhythmia control and detect any progression. Echocardiographic reassessment at intervals determined by the veterinarian tracks structural heart disease progression. Bloodwork monitoring helps ensure medication safety and detect concurrent conditions that might affect cardiac health or arrhythmia management.

Caregiver support is important for owners managing cats with cardiac disease over the long term. Understanding the nature of the condition, expected progression, and treatment goals helps owners cope with the emotional challenges of managing a chronic illness. Connecting with online support communities for owners of cats with heart disease provides shared experiences and practical tips. Open communication with the veterinary team about concerns, observations, and challenges ensures optimal care and helps address problems promptly. Financial planning for ongoing medication and monitoring costs allows sustained treatment without crisis. Discussing end-of-life considerations with the veterinary team, while difficult, helps owners feel prepared and supported when the time comes to make difficult decisions.

Certain cat breeds face elevated risk for premature ventricular contractions due to their predisposition to underlying cardiac diseases, particularly hypertrophic cardiomyopathy. Maine Coons are among the most well-documented breeds for inherited hypertrophic cardiomyopathy, with identified genetic mutations affecting cardiac muscle proteins. This predisposition to cardiomyopathy translates to increased risk for associated arrhythmias including PVCs. Ragdolls similarly carry genetic mutations associated with hypertrophic cardiomyopathy and face elevated cardiac disease and arrhythmia risk. British Shorthairs have documented predisposition to HCM, though the specific genetic basis is less well characterized than in Maine Coons and Ragdolls. Persian cats and related breeds including Himalayans and Exotic Shorthairs also show increased HCM prevalence.

Other breeds with recognized cardiac disease predisposition include Sphynx cats, which have documented hypertrophic cardiomyopathy risk, and Bengal cats, which may be predisposed to both HCM and other cardiac conditions. Norwegian Forest Cats, Siberian cats, and Scottish Folds have all been reported with increased cardiomyopathy prevalence in some populations. Devon Rex and Cornish Rex cats may have elevated risk in certain bloodlines. Domestic shorthair and domestic longhair cats, while not purebred, can certainly develop PVCs and cardiac disease, with individual risk influenced by unknown genetic factors. Mixed breed cats with ancestry from high-risk breeds may carry inherited predispositions despite their mixed heritage.

Screening recommendations for breeds at risk include echocardiographic examination before breeding and at regular intervals throughout life. The Veterinary Cardiac Genetics Laboratory offers genetic testing for specific HCM mutations in Maine Coons and Ragdolls, which can identify cats carrying disease genes before clinical disease develops. Breed clubs and responsible breeders often require cardiac screening as part of breeding programs, with results registered in databases to track disease prevalence and guide breeding decisions. Prospective owners of high-risk breeds should request documentation of parental cardiac screening and ideally obtain screening echocardiography for their own cats. Annual veterinary examinations with careful cardiac auscultation help detect early signs of heart disease, with echocardiography recommended when abnormalities are detected or for routine screening in predisposed breeds.

Premature ventricular contractions commonly co-occur with other cardiac conditions, particularly the cardiomyopathies that frequently underlie arrhythmia development. Hypertrophic cardiomyopathy, the most common heart disease in cats, frequently causes PVCs and other arrhythmias due to the abnormal myocardial architecture and altered electrical properties of thickened heart muscle. Dilated cardiomyopathy, restrictive cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy all predispose to ventricular ectopy through different mechanisms. Congestive heart failure may develop in cats with progressive cardiac disease, adding fluid management to the treatment requirements for cats already dealing with arrhythmias. Arterial thromboembolism, a devastating complication of feline cardiomyopathy, can occur in cats with heart disease regardless of arrhythmia presence.

Several conditions produce symptoms similar to those of PVCs and require differentiation during diagnostic evaluation. Other cardiac arrhythmias including supraventricular tachycardia, atrial fibrillation, and various conduction disturbances can cause similar clinical signs of weakness, collapse, or exercise intolerance. Respiratory diseases causing breathing difficulty may be mistaken for cardiac-related respiratory symptoms and vice versa. Neurological conditions causing episodic weakness or collapse require differentiation from cardiac syncope. Hyperthyroidism, while a potential cause of PVCs, can also produce symptoms including weight loss and behavior changes that may be attributed to cardiac disease. Accurate diagnosis through appropriate testing ensures proper treatment targeting the correct underlying condition.

Complications arising from PVCs and their underlying causes include progression to more serious ventricular arrhythmias such as sustained ventricular tachycardia or ventricular fibrillation, which can be life-threatening. Frequent PVCs reduce cardiac efficiency and can contribute to development or worsening of heart failure. Cats with underlying cardiomyopathy remain at risk for arterial thromboembolism regardless of arrhythmia control. Medication side effects may occur with antiarrhythmic therapy, requiring monitoring and potentially treatment adjustment. Secondary organ dysfunction from reduced cardiac output can develop in cats with severe, uncontrolled arrhythmias. Recognition and management of these potential complications requires ongoing veterinary care and monitoring.